Light up your life: Optogenetics for depression?

Journal of Psychiatry and Neuroscience

Volumn 39, Issue 1, 2014, Pages 3-5

  Albert, Paul R ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; DOXYCYCLINE; HALORHODOPSIN;

ANXIETY DISORDER; BRAIN DEPTH STIMULATION; CELL SPECIFICITY; DEPRESSION; DOPAMINERGIC NERVE CELL; EDITORIAL; HUMAN; MENTAL DISEASE; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; OPTOGENETICS; PHARMACOLOGICAL SCIENCE; POSTTRAUMATIC STRESS DISORDER; PROTEIN EXPRESSION; VENTRAL TEGMENTUM; ANIMAL; BRAIN; DEPRESSIVE DISORDER; GENE VECTOR; NERVE CELL; PATHOPHYSIOLOGY; PHOTOSTIMULATION; PHYSIOLOGY; PROCEDURES; THERAPEUTIC USE;

ANIMALS; BRAIN; DEPRESSIVE DISORDER; GENETIC VECTORS; HUMANS; NEURONS; OPTOGENETICS; PHOTIC STIMULATION;

EID: 84891784876     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.130267     Document Type: Editorial

References (17)

1. Sidor MM. Psychiatry's age of enlightenment: optogenetics and the discovery of novel targets for the treatment of psychiatric disorders. J Psychiatry Neurosci 2012;37:4-6.
2. Pail G, Huf W, Pjrek E, et al. Bright-light therapy in the treatment of mood disorders. Neuropsychobiology 2011;64:152-62.
3. Tye KM, Deisseroth K. Optogenetic investigation of neural circuits underlying brain disease in animal models. Nat Rev Neurosci 2012; 13:251-66.
4. Chaudhury D, Walsh JJ, Friedman AK, et al. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 2013;493:532-6.
5. Tye KM, Mirzabekov JJ, Warden MR, et al. Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature 2013;493:537-41.
6. Huhman KL. Social conflict models: Can they inform us about human psychopathology? Horm Behav 2006;50:640-6.
7. Bromberg-Martin ES, Matsumoto M, Hikosaka O. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 2010; 68:815-34.
8. Tye KM, Prakash R, Kim SY, et al. Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature 2011; 471: 358-62.
9. Kheirbek MA, Drew LJ, Burghardt NS, et al. Differential control of learning and anxiety along the dorsoventral axis of the dentate gyrus. Neuron 2013;77:955-68.
10. Liu X, Ramirez S, Pang PT, et al. Optogenetic stimulation of a hippocampal engram activates fear memory recall. Nature 2012; 484:381-5.
11. Ahmari SE, Spellman T, Douglass NL, et al. Repeated cortico-striatal stimulation generates persistent OCD-like behavior. Science 2013; 340:1234-9.
12. Burguière E, Monteiro P, Feng G, et al. Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors. Science 2013;340:1243-6.
13. McClements ME, MacLaren RE. Gene therapy for retinal disease. Transl Res 2013;161:241-54.
14. Weinberg MS, Samulski RJ, McCown TJ. Adeno-associated virus (AAV) gene therapy for neurological disease. Neuropharmacology 2013; 69:82-8.
15. Kennedy SH, Giacobbe P, Rizvi SJ, et al. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am J Psychiatry 2011;168:502-10.
16. Kammer T, Spitzer M. Brain stimulation in psychiatry: methods and magnets, patients and parameters. Curr Opin Psychiatry 2012; 25:535-41.
17. Hariz M, Blomstedt P, Zrinzo L. Future of brain stimulation: new targets, new indications, new technology. Mov Disord 2013;28:1784-92.